ORENCIA
Active substance: abatacept
INJECTION, SOLUTION · ABATACEPT 87.5 mg/.7mL
United StatesActive
Marketing holder: E.R. Squibb & Sons, L.L.C.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ABATACEPT · 87.5 mg/.7mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4cc3-7d43-a172-7c3b96941ce7,01a1208d-0022-724c-9d6a-1c030e857292,01a1208e-0e56-7d2e-830f-9dd520339eee,01a12091-7174-7458-a6d5-a3e71239238b;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0003-2818
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0003-2818 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0003-2818 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0003-2818 · Verified 2026-10-09 · open in source